King Abdullah University Hospital
Irbid 22110
0 studies enrolling now · 11 studies all time
What they study most
Arthritis, Rheumatoid, Colitis, Ulcerative, Complicated Urinary Tract Infection, Crohn's Disease, Fistulizing Crohns Disease, Hypercholesterolemia, Perianal Crohns Disease, Rheumatoid Arthritis, Sickle Cell Disease, Ulcerative Colitis
Studies at this site
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
- A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
- Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections — Completed